Literature DB >> 11023444

Are SHV beta-lactamases universal in Klebsiella pneumoniae?

G S Babini, D M Livermore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11023444      PMCID： PMC90049          DOI： 10.1128/AAC.44.8.2230-2230.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  4 in total

1.  Epidemiological typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units.

Authors:  M Yuan; H Aucken; L M Hall; T L Pitt; D M Livermore
Journal:  J Antimicrob Chemother       Date:  1998-05       Impact factor: 5.790

2.  Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998.

Authors:  G S Babini; D M Livermore
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

Review 3.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

Review 4.  Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.

Authors:  R Podschun; U Ullmann
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132
  4 in total
  30 in total

1.  Diversity of SHV and TEM beta-lactamases in Klebsiella pneumoniae: gene evolution in Northern Taiwan and two novel beta-lactamases, SHV-25 and SHV-26.

Authors:  F Y Chang; L K Siu; C P Fung; M H Huang; M Ho
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

2.  One new LEN enzyme and two new OKP enzymes in Klebsiella pneumoniae clinical isolates and proposed nomenclature for chromosomal beta-lactamases of this species.

Authors:  Eliane Siebor; André Péchinot; Jean-Marie Duez; Catherine Neuwirth
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

3.  Susceptibility of extended-spectrum-beta-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints.

Authors:  Peng Wang; Fupin Hu; Zizhong Xiong; Xinyu Ye; Demei Zhu; Yun F Wang; Minggui Wang
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

4.  Analysis of bla(SHV) codon 238 and 240 allele mixtures using Sybr green high-resolution melting analysis.

Authors:  Patiyan Andersson; Tegan Harris; Steven Y C Tong; Philip M Giffard
Journal:  Antimicrob Agents Chemother       Date:  2009-04-06       Impact factor: 5.191

5.  Typing of SHV extended-spectrum beta-lactamases by pyrosequencing in Klebsiella pneumoniae strains with chromosomal SHV beta-lactamase.

Authors:  Marjo Haanperä; Sofia D Forssten; Pentti Huovinen; Jari Jalava
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

6.  Novel VIM metallo-beta-lactamase variant, VIM-24, from a Klebsiella pneumoniae isolate from Colombia.

Authors:  Maria Camila Montealegre; Adriana Correa; David F Briceño; Natalia C Rosas; Elsa De La Cadena; Sory J Ruiz; Maria F Mojica; Ruben Dario Camargo; Ivan Zuluaga; Adriana Marin; John P Quinn; Maria Virginia Villegas
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

7.  Microarray-based analysis of IncA/C plasmid-associated genes from multidrug-resistant Salmonella enterica.

Authors:  Rebecca L Lindsey; Jonathan G Frye; Paula J Fedorka-Cray; Richard J Meinersmann
Journal:  Appl Environ Microbiol       Date:  2011-08-12       Impact factor: 4.792

8.  Role of SHV β-lactamase variants in resistance of clinical Klebsiella pneumoniae strains to β-lactams in an Algerian hospital.

Authors:  Nadjia Ramdani-Bouguessa; Vera Manageiro; Daniela Jones-Dias; Eugénia Ferreira; Mohamed Tazir; Manuela Caniça
Journal:  J Med Microbiol       Date:  2011-03-17       Impact factor: 2.472

9.  Selection of SHV extended-spectrum-beta-lactamase-dependent cefotaxime and ceftazidime resistance in Klebsiella pneumoniae requires a plasmid-borne blaSHV gene.

Authors:  David S Hammond; Tegan Harris; Jan Bell; John Turnidge; Philip M Giffard
Journal:  Antimicrob Agents Chemother       Date:  2007-11-12       Impact factor: 5.191

10.  Characterization of ESBL (SHV-12) producing clinical isolate of Enterobacter aerogenes from a tertiary care hospital in Nigeria.

Authors:  Murat Kasap; Kayode Fashae; Sinem Torol; Fetiye Kolayli; Fatma Budak; Haluk Vahaboglu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-01-12       Impact factor: 3.944
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.